The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins
Open accessAbstract
The binding of urokinase plaminogen activator (uPA) to its cell surface receptor (uPAR; CD87) promotes cell adhesion by increasing the affinity of the receptor for both vitronectin (VN) and integrins. We provide evidence that plasminogen activator inhibitor (PAI)-1 can detach cells by disrupting uPAR–VN and integrin–VN interactions and that it does so by binding to the uPA present in uPA–uPAR–integrin complexes on the cell surface. The detached cells cannot reattach to VN unless their surface integrins are first activated by treatment with MnCl2. Immunoprecipitation and subcellular fractionation experiments reveal that PAI-1 treatment triggers deactivation and disengagement of uPA–uPAR–integrin complexes and their endocytic clearance by the low density lipoprotein receptor–related protein. Transfection experiments demonstrate that efficient cell detachment by PAI-1 requires an excess of matrix-engaged uPA–uPAR–integrin complexes over free engaged integrins and that changes in this ratio alter the efficacy of PAI-1. Together, these results suggest a VN-independent, uPA–uPAR-dependent mechanism by which PAI-1 induces cell detachment. This pathway may represent a general mechanism, since PAI-1 also can detach cells from fibronectin and type-1 collagen. This novel “deadhesive” activity of PAI-1 toward a variety of cells growing on different extracellular matrices may begin to explain why high PAI-1 levels often are associated with a poor prognosis in human metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Cell Migration: A Physically Integrated Molecular Process
Lauffenburger, D. A., & Horwitz, A. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81280-5 · Cited by 3,915
The plasminogen activation system in tumor growth, invasion, and metastasis
Andreasen, P. A., Egelund, R., & Petersen, H. H. (2000) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050497 · Cited by 943
The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin
Stefansson, S., & Lawrence, D. A. (1996) · Nature · doi:10.1038/383441a0 · Cited by 674
Huttenlocher, A. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80112-x · Cited by 513
Novel purification of vitronectin from human plasma by heparin affinity chromatography.
Yatohgo, T., Izumi, M., Kashiwagi, H., & Hayashi, M. (1988) · Cell Structure and Function · doi:10.1247/csf.13.281 · Cited by 510
Herz, J., Goldstein, J. L., Strickland, D. K., Ho, Y. K., & Brown, M. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54845-6 · Cited by 482
The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?
Murphy-Ullrich, J. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12609 · Cited by 476
Deng, G., Curriden, S. A., Wang, S., Rosenberg, S., & Loskutoff, D. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.6.1563 · Cited by 448
Self-citationThe urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.
Foekens, J. A., Peters, H. A., Look, M. P., Portengen, H., Schmitt, M., Kramer, M. D., Brünner, N., Jänicke, F., Gelder, M. E. M., Henzen-Logmans, S. C., et al. (2000) · PubMed · Cited by 419
Liu, D., Ghiso, J. A. A., Estrada, Y., & Ossowski, L. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00072-7 · Cited by 392
Ossowski, L., & Aguirre-Ghiso, J. A. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00140-x · Cited by 380
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
Nykjar, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2610 · Cited by 309
Waltz, D. A., Natkin, L. W., Fujita, R. M., Wei, Y., & Chapman, H. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119521 · Cited by 288
Dunn, K. W., McGraw, T. E., & Maxfield, F. R. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.6.3303 · Cited by 275
Czekay, R.-P., Kuemmel, T. A., Orlando, R. A., & Farquhar, M. G. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.5.1467 · Cited by 193
Self-citationAccessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
Cubellis, M. V., Andreasen, P., Ragno, P., Mayer, M., Danø, K., & Blasi, F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.4828 · Cited by 180
Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1
Stefansson, S., Petitclerc, E., Wong, M. K., McMahon, G. A., Brooks, P. C., & Lawrence, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007609200 · Cited by 177
Tarui, T., Mazar, A. P., Cines, D. B., & Takada, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008220200 · Cited by 174
Regulation of cell adhesion by PAI‐1
Loskutoff, D. J., Curriden, S. A., Hu, G., & Deng, G. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01526.x · Cited by 155
Self-citationPampori, N. A., Hato, T., Stupack, D. G., Aïdoudi, S., Cheresh, D. A., Nemerow, G. R., & Shattil, S. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21609 · Cited by 155
Structure of plasminogen activator inhibitor 1 (PAI-1) and its function in fibrinolysis: an update
van Meijer, M., & Pannekoek, H. (1995) · Fibrinolysis and Proteolysis · doi:10.1016/s0268-9499(95)80015-8 · Cited by 154
Deng, G. G., Curriden, S. A., Hu, G., Czekay, R., & Loskutoff, D. J. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1133 · Cited by 124
Self-citationKjøller, L. (2002) · Biological Chemistry · doi:10.1515/bc.2002.002 · Cited by 112
Webb, D. J., Thomas, K. S., & Gonias, S. L. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.4.741 · Cited by 100
Witte, J., Foekens, J. A., Brünner, N., Heuvel, J. J. T. M., van Tienoven, T., Look, M. P., Klijn, J. G. M., Geurts-Moespot, A. J., Grebenchtchikov, N. I., Benraad, T. J., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1867 · Cited by 43
Kinetic analysis of integrin‐dependent cell adhesion on vitronectin
Germer, M., Kanse, S. M., Kirkegaard, T., Kjøller, L., Felding‐Habermann, B., Goodman, S. L., & Preissner, K. T. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2530669.x · Cited by 40
Binding of Human Single Chain Urokinase to Chinese Hamster Ovary Cells and Cloning of Hamster u-PAR
Fowler, B. J., Mackman, N., Parmer, R. J., & Miles, L. A. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615154 · Cited by 21
Cited by
Role of tumor-associated macrophages in tumor progression and invasion
Mantovani, A., Schioppa, T., Porta, C., Allavena, P., & Sica, A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9001-7 · Cited by 888
The Role of Hypoxia-Induced Factors in Tumor Progression
Vaupel, P. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90005-10 · Cited by 827
Emami Nejad, A., Najafgholian, S., Rostami, A., Sistani, A., Shojaeifar, S., Esparvarinha, M., Nedaeinia, R., Haghjooy Javanmard, S., Taherian, M., Ahmadlou, M., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01719-5 · Cited by 693
Lillis, A. P., Van Duyn, L. B., Murphy-Ullrich, J. E., & Strickland, D. K. (2008) · Physiological Reviews · doi:10.1152/physrev.00033.2007 · Cited by 669
Gelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 661
Metadata
- Authors
- Czekay, R.-P., Aertgeerts, K., Curriden, S. A., & Loskutoff, D. J.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2003-03-03
- Volume
- 160
- Issue
- 5
- Pages
- 781-791
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2131602901
- Cited by
- 304
- References
- 28
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.